bioAffinity Technologies, Inc.
For the period ended Oct 23, 2026. Filed Oct 23, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Oct 23, 2026 · Filed Oct 23, 2026
Use the contents to explore the available documents and sections.
Contents
Board Discretion to Implement the Authorized Share Decrease
The Board believes that stockholder adoption and approval of the Authorized Share Decrease is in the best interests of our stockholders. If our stockholders approve this Proposal No. 4, the Board will implement the Authorized Share Decrease only upon a determination that the Authorized Share Decrease is in the best interests of the stockholders at that time. The Board may abandon the Authorized Share Decrease in its sole discretion.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.